000			02154 a2200613 4500
005			20250516214616.0
264		0	_c20150224
008			201502s 0 0 eng d
022			_a1471-2407
024	7		_a10.1186/1471-2407-14-340 _2doi
040			_aNLM _beng _cNLM
100	1		_aKjersem, Janne B
245	0	0	_aFCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab. _h[electronic resource]
260			_bBMC cancer _cMay 2014
300			_a340 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCetuximab
650	0	4	_aColorectal Neoplasms _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLeucovorin _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aOrganoplatinum Compounds _xadministration & dosage
650	0	4	_aOxaliplatin
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aProportional Hazards Models
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aProto-Oncogene Proteins p21(ras)
650	0	4	_aReceptors, IgG _xgenetics
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
650	0	4	_aras Proteins _xgenetics
700	1		_aSkovlund, Eva
700	1		_aIkdahl, Tone
700	1		_aGuren, Tormod
700	1		_aKersten, Christian
700	1		_aDalsgaard, Astrid M
700	1		_aYilmaz, Mette K
700	1		_aFokstuen, Tone
700	1		_aTveit, Kjell M
700	1		_aKure, Elin H
773	0		_tBMC cancer _gvol. 14 _gp. 340
856	4	0	_uhttps://doi.org/10.1186/1471-2407-14-340 _zAvailable from publisher's website
999			_c23875957 _d23875957